Clinical trial
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
NCT00006682 · Medstar Health Research Institute, Other · Completed
Key facts
| NCT number | NCT00006682 |
|---|---|
| Title | Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer |
| Official title | An Open-Label Phase II Study of Navelbine (Vinorelbine Tartrate) and Taxotere (Docetaxel) as First-Line Therapy for Metastatic Breast Cancer |
| Lead sponsor | Medstar Health Research Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, vinorelbine ditartrate |
| Start date | Feb 1, 2000 |
| Primary completion | Jan 22, 2002 |
| Completion | Jan 22, 2002 |
| First posted | May 4, 2004 |
| Last update posted | Aug 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: